Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

The human gastrointestinal tract is populated with a diverse microbial community. The vast genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every aspect of human biology, including health maintenance, development, aging, and disease. The advent of new sequencing technologies and culture-independent methods has allowed researchers to move beyond correlative studies toward mechanistic explorations to shed light on microbiome–host interactions. Evidence has unveiled the bidirectional communication between the gut microbiome and the central nervous system, referred to as the “microbiota–gut–brain axis”. The microbiota–gut–brain axis represents an important regulator of glial functions, making it an actionable target to ameliorate the development and progression of neurodegenerative diseases. In this review, we discuss the mechanisms of the microbiota–gut–brain axis in neurodegenerative diseases. As the gut microbiome provides essential cues to microglia, astrocytes, and oligodendrocytes, we examine the communications between gut microbiota and these glial cells during healthy states and neurodegenerative diseases. Subsequently, we discuss the mechanisms of the microbiota–gut–brain axis in neurodegenerative diseases using a metabolite-centric approach, while also examining the role of gut microbiota-related neurotransmitters and gut hormones. Next, we examine the potential of targeting the intestinal barrier, blood–brain barrier, meninges, and peripheral immune system to counteract glial dysfunction in neurodegeneration. Finally, we conclude by assessing the pre-clinical and clinical evidence of probiotics, prebiotics, and fecal microbiota transplantation in neurodegenerative diseases. A thorough comprehension of the microbiota–gut–brain axis will foster the development of effective therapeutic interventions for the management of neurodegenerative diseases.

• Publication year

  2024

• Venue

  Signal Transduction and Targeted Therapy

• Publication date

  2024-02-16

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/s41392-024-01743-1PMID 38360862PMCID 10869798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration.

  2023cited by this paper
• To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson’s disease

  2023cited by this paper
• Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice

  2023cited by this paper
• Targeting the human gut microbiome with small-molecule inhibitors

  2023cited by this paper
• A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

  2023cited by this paper
• Cellular senescence in white matter microglia is induced during ageing in mice and exacerbates the neuroinflammatory phenotype

  2023cited by this paper
• The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease.

  2023cited by this paper
• An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants

  2023cited by this paper
• Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics

  2023cited by this paper
• The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice

  2023cited by this paper
• Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson’s Disease

  2023cited by this paper
• Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence

  2023cited by this paper
• Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer’s disease

  2023cited by this paper
• Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS

  2023cited by this paper
• Molecular subtypes of ALS are associated with differences in patient prognosis

  2023cited by this paper
• A nationwide cohort study on diabetes severity and risk of Parkinson disease

  2023cited by this paper
• TMAO promotes dementia progression by mediating the PI3K/Akt/mTOR pathway.

  2023cited by this paper
• Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids

  2023cited by this paper
• Impaired dopamine release in Parkinson’s disease

  2023cited by this paper
• The gut microbiome modulates the transformation of microglial subtypes

  2023cited by this paper
• Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis

  2023cited by this paper
• Assembling symbiotic bacterial species into live therapeutic consortia that reconstitute microbiome functions.

  2023cited by this paper
• Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments

  2023cited by this paper
• Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.

  2023cited by this paper
• Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline

  2023cited by this paper
• The contribution of the peripheral immune system to neurodegeneration

  2023cited by this paper
• Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson’s Disease Model Mice

  2023cited by this paper
• Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment

  2023cited by this paper
• Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes

  2023cited by this paper
• The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

  2023cited by this paper
• Carbohydrate complexity limits microbial growth and reduces the sensitivity of human gut communities to perturbations

  2023cited by this paper
• Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment

  2023cited by this paper
• Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies

  2023cited by this paper
• A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation.

  2023cited by this paper
• In-depth investigation of the mechanisms of Schisandra chinensis polysaccharide mitigating Alzheimer's disease rat via gut microbiota and feces metabolomics.

  2023cited by this paper
• The effect of a pharmaceutical ghrelin agonist on lifespan in C57BL/6J male mice: A controlled experiment

  2023cited by this paper
• Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection

  2023cited by this paper
• Hallmarks of neurodegenerative diseases.

  2023cited by this paper
• Dietary choline metabolite TMAO impairs cognitive function and induces hippocampal synaptic plasticity declining through the mTOR/P70S6K/4EBP1 pathway.

  2023cited by this paper
• Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity

  2023cited by this paper
• β‐Glucan attenuates cognitive impairment of APP/PS1 mice via regulating intestinal flora and its metabolites

  2023cited by this paper
• Microbiota alters the metabolome in an age- and sex- dependent manner in mice

  2023cited by this paper
• The Integrity of the Blood–Brain Barrier as a Critical Factor for Regulating Glutamate Levels in Traumatic Brain Injury

  2023cited by this paper
• Gut Microbiota Metabolites Differentially Release Gliotransmitters from the Cultured Human Astrocytes: A Preliminary Report

  2023cited by this paper
• Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.

  2023cited by this paper
• Deciphering the quorum-sensing lexicon of the gut microbiota.

  2023cited by this paper
• Gut microbiome dysbiosis across early Parkinson’s disease, REM sleep behavior disorder and their first-degree relatives

  2023cited by this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cited by this paper
• Profiling the human intestinal environment under physiological conditions

  2023cited by this paper
• Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta‐analysis

  2023cited by this paper
• Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites

  2023cited by this paper
• Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity via AMPK/SOD2 Pathway

  2023cited by this paper
• Metabolic landscape of the male mouse gut identifies different niches determined by microbial activities

  2023cited by this paper
• Altered gut microbiota in older adults with mild cognitive impairment: a case-control study

  2023cited by this paper
• Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

  2023cited by this paper
• Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer’s disease

  2023cited by this paper
• Amelioration of olfactory dysfunction in a mouse model of Parkinson’s disease via enhancing GABAergic signaling

  2023cited by this paper
• A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.

  2023cited by this paper
• Defining blood-induced microglia functions in neurodegeneration through multiomic profiling

  2023cited by this paper
• Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

  2023cited by this paper
• Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease

  2023cited by this paper
• Regulatory T cells in the face of the intestinal microbiota

  2023cited by this paper
• Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration

  2023cited by this paper
• The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis

  2023cited by this paper
• T_H17 cell heterogeneity and its role in tissue inflammation

  2023cited by this paper
• Insights into Alzheimer’s disease from single-cell genomic approaches

  2023cited by this paper
• C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain

  2023cited by this paper
• ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy

  2023cited by this paper
• Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model

  2023cited by this paper
• Fecal microbiota transplantation improves VPA-induced ASD mice by modulating the serotonergic and glutamatergic synapse signaling pathways

  2023cited by this paper
• Gut microbiota-derived metabolites mediate the neuroprotective effect of melatonin in cognitive impairment induced by sleep deprivation

  2023cited by this paper
• The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored

  2023cited by this paper
• Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin

  2023cited by this paper
• Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease

  2023cited by this paper
• Impact of aging on meningeal gene expression

  2023cited by this paper
• Mechanisms of myeloid cell entry to the healthy and diseased central nervous system

  2023cited by this paper
• The human gut microbiome of athletes: metagenomic and metabolic insights

  2023cited by this paper
• Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease

  2023cited by this paper
• Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

  2023cited by this paper
• The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries.

  2023cited by this paper
• Basal forebrain cholinergic signalling: development, connectivity and roles in cognition

  2023cited by this paper
• The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases

  2023cited by this paper
• Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

  2023cited by this paper
• Onset age of diabetes and incident dementia: A prospective cohort study.

  2023cited by this paper
• Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

  2023cited by this paper
• Bifidobacterium breve HNXY26M4 Attenuates Cognitive Deficits and Neuroinflammation by Regulating the Gut-Brain Axis in APP/PS1 Mice.

  2023cited by this paper
• Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice

  2023cited by this paper
• Shorter sleep time relates to lower human defensin 5 secretion and compositional disturbance of the intestinal microbiota accompanied by decreased short-chain fatty acid production

  2023cited by this paper
• Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis

  2023cited by this paper
• Promotion of astrocyte-neuron glutamate-glutamine shuttle by SCFA contributes to the alleviation of Alzheimer's disease.

  2023cited by this paper
• APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles

  2023cited by this paper
• The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from perspective cohort studies of supplementation, dietary intake, and blood markers.

  2023cited by this paper
• Longevity of centenarians is reflected by the gut microbiome with youth-associated signatures

  2023cited by this paper
• Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments

  2023cited by this paper
• Quantifying bias introduced by sample collection in relative and absolute microbiome measurements

  2023cited by this paper
• Targeting epigenetic modifications in Parkinson's disease therapy

  2023cited by this paper
• Roles of the gut microbiome in weight management

  2023cited by this paper
• Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease

  2023cited by this paper
• Human metabolome variation along the upper intestinal tract

  2023cited by this paper
• Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.

  2023cited by this paper

• Modulation of the Kynurenine Pathway: A New Approach for Treating Neurodegeneration.

  2026cites this paper
• The relationship between gut microbiota and neurodegenerative diseases: a genetic and epigenetic perspective

  2026cites this paper
• Genetic evidence on chemical communication between gut microbiota and neurological and psychiatric disorders: a Mendelian randomization study.

  2026cites this paper
• Yinhua Gouteng decoction alleviates tic disorder symptoms by modulating neuro-inflammation in a rat model.

  2026cites this paper
• The promise of GLP-1 receptor agonists for neurodegenerative diseases

  2026cites this paper
• Probiotic Spore-Based Oral Biotherapeutics Promote Brain Targeting toward Gut-Brain Dual-Regulation for Parkinson's Disease Treatment.

  2026cites this paper
• Gut virome plays an extended role with bacteriome in neurological health and disease.

  2026cites this paper
• Age-driven dysbiosis: gut microbiota in the pathogenesis and treatment of aging disorders

  2026cites this paper
• Gut dysbiosis in neurodevelopmental disorders: linking microbiota signatures to cognitive rigidity in autism spectrum disorder

  2026cites this paper
• Meconium metabolomic profiling dysregulation and neonatal brain injury in selective fetal growth restriction.

  2026cites this paper
• Using Plant-Derived Polysaccharides in the Management of Cognitive Disorders: Molecular and Clinical Perspectives.

  2026cites this paper
• Fish (Alaska Pollock) protein intake attenuates age-related short-term memory decline through gut microbiota modulation.

  2026cites this paper
• Muribaculum intestinale in brain-gut axis regulation: promises and limitations for therapeutic applications.

  2026cites this paper
• Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment.

  2026cites this paper
• Harnessing Dietary Tryptophan: Bridging the Gap Between Neurobiology and Psychiatry in Depression Management

  2026influential citation
• Elevated fecal silver, lithium, and platinum in cognitive impairment: A pilot exploration of microbiota-metal interactions.

  2026cites this paper
• Tryptophan metabolism at the crossroads of the neuro-immuno-microbial axis: implications for precision medicine in chronic diseases

  2026cites this paper
• Dietary Modulation of the Gut–Immune–Brain Axis: Nutritional Immunoepigenomics for Immune Regulation in Autoimmunity, Cancer, and Infection

  2026cites this paper
• Harnessing meat byproducts for health: bioactive peptides to modulate gut microbiota and promote sustainability

  2026cites this paper
• When metabolic strategies fall short: The unaddressed role of food addiction

  2026cites this paper
• Dietary and metabolic reprogramming alleviates neurodegeneration: a review of mechanisms and clinical implications

  2026cites this paper
• Polyphenol-Loaded Plant Extracellular Vesicles: A New Approach to Combat AGEs-Induced Neurotoxicity via the Microbiota-Gut-Brain Axis.

  2026cites this paper
• Changes in Gut Microbiota and Brain Function in Rats Fed with a copper-overloaded Diet.

  2026cites this paper
• Role of Gut Microbiota in Psychiatric Disorders: From Mechanistic Insights to Therapeutic Strategies.

  2026cites this paper
• Spirocyclic Adduct Formation of Tryptanthrin with Indole Monoamines under Biomimetic Acidic Conditions.

  2026cites this paper
• Psychobiotics for the treatment of neuropsychiatric, neurodegenerative, and neurodevelopmental disorders: A systematic review.

  2026cites this paper
• Akkermansia muciniphila reduces neuroinflammation and Aβ deposition via tryptophan metabolism in the APP/PS1 mouse model of Alzheimer’s disease

  2026cites this paper
• Advances in fucoidan extraction and structure-bioactivity relationships

  2026cites this paper
• An integrated analysis of spinal cord transcriptome and gut microbiome unravel age-associated host-microbiome interactions following spinal cord injury

  2026cites this paper
• Gut microbiota transmission induces cognitive impairment through amyloid pathology in wild-type mice.

  2026cites this paper
• An Explainable Knowledge Graph-Driven Approach to Decipher the Link Between Brain Disorders and the Gut Microbiome

  2026cites this paper
• Foodborne Carbon Dots Trigger Appetite Suppression: Mechanistic Insights from the Microbiota–Gut–Brain Axis

  2026cites this paper
• Advances in Dietary Modulation of the Intestinal Barrier: Mechanistic, Structural, and Functional Insights.

  2026cites this paper
• The aging gut-glia-immune axis in alzheimer's disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation.

  2026cites this paper
• The gut microbiota influences neurodegenerative diseases through the gut-brain axis: molecular mechanisms and effects on immune function

  2026cites this paper
• G Protein-Coupled Receptors in Irritable Bowel Syndrome: Mechanisms and Therapeutic Opportunities

  2026cites this paper
• Parabacteroides distinguishes bipolar disorder from schizophrenia: toward a microbial biomarker for differential diagnosis

  2026cites this paper
• Postbiotics and the gut-brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging.

  2026cites this paper
• Gut metabolite indole-3-acetic acid aggravates neuropsychiatric lupus via the AHR/STAT3 pathway in microglia

  2026cites this paper
• Oligopeptides from Gynura divaricata improve glycemic control via inhibition of gluconeogenesis and gut-brain axis regulation.

  2026cites this paper
• Advanced LC-MS/MS Methodologies for the Analysis of Neuroactive Compounds in Tomato-Based Diets: Insights from 2D In Vitro Digestion Models

  2026cites this paper
• Neurotrauma and the Gut–Brain Axis: Mechanistic Insights and Therapeutic Implications

  2026cites this paper
• A gut-activated NHR-86–CYP pathway mediates the neuroprotective effects of Enterococcus faecium probiotics in a nematode model of amyotrophic lateral sclerosis

  2026cites this paper
• Multi-Omics Profiling of mTBI-Induced Gut-Brain Axis Disruption: A Preliminary Study for Biomarker Screening and Mechanistic Exploration.

  2026cites this paper
• Gut Microbiota-Derived Metabolites as Immune Modulators in Aging and Age-Related Chronic Inflammatory Diseases.

  2026cites this paper
• “Unfolding Parkinson’s Disease Through the Microbiome-Gut-Brain Axis”

  2026cites this paper
• Neuroimmune Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Strategies.

  2026cites this paper
• Airborne particulates and brain health: The role of PM2.5 in blood-brain-barrier dysfunction.

  2026cites this paper
• Acer truncatum Bunge seed oil attenuates learning and memory impairment in AD mouse model via modulating gut microbiota and metabolism.

  2026cites this paper
• The role of indole metabolites derived from gut microbiota in parkinson's disease: A comprehensive review.

  2026cites this paper
• Soy and the gut microbiome: a bi-directional relationship shaping nutrition and health

  2026cites this paper
• The Gut–Brain–Immune Axis in Glioma: Emerging Mechanisms and Therapeutic Opportunities

  2026cites this paper
• Gut microbiota and brain aging: a comparative review of African and western populations.

  2026cites this paper
• Neuroinflammation in Alzheimer's Disease: The Role of Obesity, Gut Microbiota, and Therapeutic Potential of Omega-3 Fatty Acids and Neural Stem Cells.

  2026cites this paper
• Unveiling Shared Genetic Architectures and Causality: Intestinal Diseases and Neurological Diseases

  2026cites this paper
• Exploring Bifidobacteria-Fermented Dairy Products: Innovations, Challenges, and Health-Related Insights

  2026cites this paper
• Neurovascular interactions in the ageing heart.

  2026cites this paper
• Unlocking the secrets of gut microbiota: The untapped potential of Caenorhabditis elegans.

  2026cites this paper
• Bibliometric analysis of research hotspots and trends regarding the interplay between gut microbiota and microglia.

  2026cites this paper
• Maternal intestinal dysbiosis mediated by sevoflurane exposure during pregnancy leads to altered gut microbiota and metabolites and cognitive dysfunction in the offspring.

  2026cites this paper
• Evaluation of the effect of essential oil fumigation on antioxidant properties and biological activity of Boletus edulis and Imleria badia - in vitro assessment with HT-29, RAW 264.7, and SH-SY5Y cell lines.

  2026cites this paper
• Gut microbial metabolites in inflammatory bowel disease: immunological mechanisms regulating Treg/Th17 balance and therapeutic potential

  2026cites this paper
• The role of traditional Chinese medicine in alleviating neuropsychiatric disorders via the gut microbiota

  2026cites this paper
• Plant-derived bioactive peptides in anti-aging applications: From molecular mechanisms to advanced delivery platforms

  2026cites this paper
• Mechanistic insights into ginsenoside Rd nanoparticles-mediated protection against memory impairment: From preparation and physicochemical characterization to in vivo efficacy.

  2026cites this paper
• The Enteric Nervous System as a Mediator of Microbiota‐Gut‐Brain Interactions in Parkinson's Disease

  2026cites this paper
• Effects of plain water intake before bedtime on sleep and depressive mood among middle-aged Japanese men

  2026cites this paper
• RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson’s disease mouse model

  2026cites this paper
• Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment

  2026cites this paper
• Glycine attenuates sepsis-induced white matter injury by modulating gut microbiota

  2026cites this paper
• Bile acids as therapeutic agents

  2026cites this paper
• Exploring gut microbiota mechanisms in frailty induced by 5-hydroxymethylfurfural: evidence from mouse models and Mendelian randomization

  2026cites this paper
• Nutritional Modulation of Biochemical Pathways in Stress Response: A Comprehensive Review

  2026cites this paper
• Co-Biotics - Dual Modulation of the Host and the Microbiota

  2026cites this paper
• Gramineae Wheat Germ Extract Ameliorates Methylglyoxal-Induced Neurobehavioral Deficits Through Modulation of the Gut Microbiota and Tryptophan Metabolism.

  2026cites this paper
• Wilson’s disease-associated gut dysbiosis: novel insights into microbial functional alterations, virulence changes, and resistance markers

  2026cites this paper
• Complex Interactions Between Stress, Nutrition, Gut Microbiota, and Infectious Diseases and Their Impact on Health in Global Conflicts: A Narrative Review.

  2026cites this paper
• Dead but not gone: the interplay between the programmed cell death process and surrounding bacteria

  2026cites this paper
• Fecal microbiota transplantation promotes Wnt3a-mediated hippocampal neurogenesis in a rat model of chronic cerebral hypoperfusion

  2026cites this paper
• Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

  2026cites this paper
• Lipid metabolism and metabolites: emerging roles in systemic physiology and metabolic diseases.

  2026cites this paper
• Oligodendrocytes at the Crossroads: Central Players and Interactive Partners in White Matter Aging.

  2026cites this paper
• Interplay Between Nicotinamide Mononucleotide and Microbiota: A New Avenue in Metabolic Health

  2026cites this paper
• Decoding the microbial blueprint of pancreatic cancer

  2026cites this paper
• Assessing the Roles of Aging, Estrogen, Nutrition, and Neuroinflammation in Women and Their Involvement in Alzheimer’s Disease—A Narrative Overview

  2026influential citation
• Insulin Resistance and Inflammation

  2026cites this paper
• PRISM‐xQTL: Pleiotropic Relationships Integrated with System‐level Multiomic QTL analysis for causal genes and molecular mediators in Alzheimer's disease

  2026cites this paper
• Gut Microbiota and Stroke: New Insights into the Gut–Brain–Vascular Axis

  2026cites this paper
• Pathogenesis of Bovine Mastitis and Influence of the Gut Microbiota: A Review.

  2026cites this paper
• Targeting gut-brain-immune axis in amyotrophic lateral sclerosis

  2026cites this paper
• Nose-to-brain axis: mechanistic links between nasal microbiome dysbiosis, neuroinflammation, and brain disorders.

  2026cites this paper
• Gut Dysbiosis and Microbiota-Derived Metabolites in Neurodegenerative Diseases: Molecular and Biochemical Mechanisms Along the Gut–Brain Axis

  2026cites this paper
• Gut-brain axis in health and brain disease.

  2026cites this paper
• Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer's disease-like pathology in mice.

  2026cites this paper
• Plant-derived bioactive compounds modulate the gut microbiota in Alzheimer's disease: Metabolite signaling, neuroimmune circuits, and systems-level regulation.

  2026cites this paper
• A 3D gut-brain-vascular platform for bidirectional crosstalk in gut-neuropathogenesis.

  2026cites this paper
• Micro/nanoplastic-mediated gut dysbiosis and its impact on cardiac and neuroimmune function in zebrafish model: A multi-omics approach.

  2026cites this paper
• Nanotherapeutic Interventions for Parkinson’s Disease: Modulating Pathogenic Mechanisms and Overcoming Therapeutic Obstacles

  2026cites this paper
• Spontaneous axon regeneration is preserved despite gut microbiota disruption after spinal cord injury in lampreys

  2026cites this paper
• Insulin resistance and SIRT1 dysregulation in neurodegenerative diseases.

  2026cites this paper